ToposBio
AI-driven protein modeling company expanding druggable space for drug discovery.
New signals are running late.
Delayed 14 days1 tracked investors and operators follow ToposBio
Who followed
Showing 1 of 1.
Karsten Kreis
NVIDIA / investor
Follow timeline
Delayed 14 days. Pro shows follows as we spot them.
Karsten Kreis (NVIDIA) Baseline
A follow shows attention, not a funding round or investment advice.